Recent Progress in Tumor Virology Research

Clinical trials have indicated that oncoviruses might be developed as safe and effective anticancer agents. No​vel strategies can be used to facilitate viral evasion of the immune system, the prevention of viral uptake by the liver, and an increased specificity for tumour cells, either at the cell surface or through intracellular restriction.

  • The search for novel tumor viruses
  • Understanding human carcinogenesis by using tumor viruses as experimental tools
  • Defense against the use of viruses in bioterrorism

Recent Progress in Tumor Virology Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in